Two Sigma Securities, LLC Navidea Biopharmaceuticals, Inc. Transaction History

Two Sigma Securities, LLC

  • $8.19 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.07 - $0.12 $1,942 - $3,330
-27,756 Reduced 46.8%
31,553 $2,000
Q2 2023

Aug 14, 2023
BUY
$0.08 - $0.29 $3,198 - $11,595
39,984 Added 206.9%
59,309 $5,000
Q1 2023

May 15, 2023
SELL
$0.24 - $0.34 $436 - $618
-1,820 Reduced 8.61%
19,325 $5,000
Q4 2022

Feb 14, 2023
BUY
$0.18 - $0.3 $3,806 - $6,343
21,145 New
21,145 $4,000
Q2 2022

Aug 15, 2022
BUY
$0.63 - $1.1 $8,511 - $14,861
13,510 New
13,510 $10,000

Others Institutions Holding NAVB

# of Institutions
3
Shares Held
10.4K
Call Options Held
0
Put Options Held
0
View Full List

About NAVIDEA BIOPHARMACEUTICALS, INC.

NAVB Quotes by TradingView
  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email